What exactly did BMO do in the March 03, 2026 update?

On March 03, 2026 BMO Capital **maintained** a Market Perform rating on Stride, Inc. The note cited a settlement with GMCS but no change to the firm’s outlook, leaving the LRN analyst rating neutral rather than bullish or bearish.

How should investors interpret a Market Perform LRN analyst rating?

Market Perform indicates a neutral view: expect returns roughly in line with peers or the market. For LRN this rating suggests holding existing positions but not adding exposure based solely on the BMO update.

Did BMO change Stride’s price target in the note?

BMO did not publish a new price target in the March 03, 2026 note. The broader analyst set shows an average target near **$106.33**, which investors can use alongside the LRN analyst rating.

What are the next catalysts that could alter the LRN analyst rating?

Key catalysts include upcoming earnings, enrollment trends, contract renewals, and any further legal developments. Material changes on those fronts could trigger analyst upgrades or downgrades to the LRN analyst rating.

Analyst Ratings

BMO Maintains Market Perform on Stride, Inc. (LRN) Mar 03, 2026

ByHuzaifa Zahoor March 4, 2026March 4, 2026

BMO Capital maintained a Market Perform rating on Stride, Inc. (LRN) on March 03, 2026 at 11:30 AM. This LRN analyst rating follows Stride’s settlement with GMCS and arrives as the shares showed a -0.92% (-$0.8) move since the note. The firm cited no material change to its view after the settlement, keeping guidance and near-term risk assumptions intact. Investors should read this as a neutral stance rather than a buy or sell trigger, given the legal clarity but continuing execution risks.